title: Is docetaxel now an essential component of neoadjuvant breast chemotherapy?
authors.forename: Nasir
authors.initials: N
authors.lastname: Shahab
authors.forename: Syed
authors.initials: S
authors.lastname: Haider
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D023381:Endpoint Determination; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D015203:Reproducibility of Results; D016019:Survival Analysis; D043823:Taxoids / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D004317:Doxorubicin; D003520:Cyclophosphamide